Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Muscarinic acetylcholine receptor M2 | ||
Ligand | BDBM50522816 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_1888527 (CHEMBL4390204) | ||
Ki | 12±n/a nM | ||
Citation | Yamashita, Y; Tanaka, KI; Yamakawa, N; Asano, T; Kanda, Y; Takafuji, A; Kawahara, M; Takenaga, M; Fukunishi, Y; Mizushima, T Chemical modification-mediated optimisation of bronchodilatory activity of mepenzolate, a muscarinic receptor antagonist with anti-inflammatory activity. Bioorg Med Chem27:3339-3346 (2019) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Muscarinic acetylcholine receptor M2 | |||
Name: | Muscarinic acetylcholine receptor M2 | ||
Synonyms: | ACM2_HUMAN | CHRM2 | Cholinergic, muscarinic M2 | Muscarinic acetylcholine receptor M2 and M4 | Muscarinic acetylcholine receptor M2 and M5 | RecName: Full=Muscarinic acetylcholine receptor M2 | ||
Type: | GPCR | ||
Mol. Mass.: | 51730.61 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P08172 | ||
Residue: | 466 | ||
Sequence: |
| ||
BDBM50522816 | |||
n/a | |||
Name | BDBM50522816 | ||
Synonyms: | CHEMBL4567385 | ||
Type | Small organic molecule | ||
Emp. Form. | C31H36BrNO4 | ||
Mol. Mass. | 566.526 | ||
SMILES | [Br-].OC(C(=O)OC1C[N+]2(CCCOCc3ccccc3)CCC1CC2)(c1ccccc1)c1ccccc1 |(14.86,-34.45,;3.91,-35.36,;5.25,-36.13,;6.59,-36.9,;6.59,-38.44,;7.92,-36.12,;9.26,-36.89,;10.58,-36.11,;11.91,-36.89,;13.24,-36.12,;14.58,-36.9,;15.91,-36.13,;17.24,-36.9,;18.58,-36.13,;19.91,-36.91,;19.9,-38.45,;21.23,-39.22,;22.57,-38.45,;22.57,-36.91,;21.24,-36.14,;11.91,-38.43,;10.58,-39.19,;9.26,-38.43,;10.75,-38.23,;10.4,-37.18,;5.25,-34.59,;6.58,-33.82,;6.58,-32.28,;5.24,-31.52,;3.9,-32.3,;3.91,-33.83,;3.92,-36.91,;2.59,-36.13,;1.26,-36.91,;1.26,-38.45,;2.6,-39.21,;3.93,-38.44,)| | ||
Structure |